PP
CRHM

Paloma Partners’s CRH Medical Corporation CRHM Stock Holding History

Paloma Partners’s Portfolio CRHM Stock Details CRHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-34,500
Closed -$91K – 2371
2017
Q4 		$91K Buy
+34,500
New +$77K ﹤0.01% 1799

Other funds holding CRHM

Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paloma Partners's CRHM Position: Q1 2018 in Review

Paloma Partners sold out of CRH Medical Corporation (CRHM) in Q1 2018, closing a stake of 34,500 shares — an estimated $91K sold.

Paloma Partners first reported a position in CRHM in Q4 2017 and held it in 1 quarter. The position peaked at $91K in Q4 2017. 34 funds tracked by Wall St. Rank hold CRHM as of Q1 2018.

  • Paloma Partners reported no remaining CRH Medical Corporation position as of Q1 2018 after selling out during the quarter.
  • Paloma Partners sold 34,500 CRH Medical Corporation shares in Q1 2018, an estimated $91K.
  • Paloma Partners first reported a position in CRH Medical Corporation in Q4 2017 and held it in 1 quarter.
  • Paloma Partners's CRH Medical Corporation position peaked at $91K in Q4 2017.
  • 34 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q1 2018.

Based on Paloma Partners's 13F filing for Q1 2018, filed 15 May 2018.